Related Experiment Video
Updated: Jun 10, 2025
06:01
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
9.4K
Mutational analysis differentiating sporadic carcinomas from colitis-associated colorectal carcinomas
Theresa Dregelies1,2, Franziska Haumaier1, William Sterlacci1
1Institut für Pathologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Klinikum Bayreuth, Preuschwitzer Str. 101, 95445, Bayreuth, Germany.
Cell Communication and Signaling : CCS
|October 10, 2024
Summary
Genetic differences between colitis-associated carcinoma (CAC) and sporadic colorectal carcinoma (sCRC) were identified. Specific gene mutations, like KRAS G12D in CAC, can aid pathologists in distinguishing these cancers.
Area of Science:
- Oncology
- Gastroenterology
- Genetics
Background:
- Ulcerative colitis (UC) increases risk for colitis-associated carcinoma (CAC).
- CAC shares genetic and histologic similarities with sporadic colorectal carcinoma (sCRC), complicating diagnosis.
- Accurate categorization is crucial due to differing clinical outcomes.
Purpose of the Study:
- To identify genetic variants distinguishing CAC from sCRC.
- To aid pathologists in accurate cancer diagnosis.
Main Methods:
- Analyzed mutation profiles of 64 CACs and sCRCs across 50 cancer-associated genes.
- Compared mutation data to 29 controls.
- Utilized statistical analyses including Pearson Chi-Square and Fisher's exact tests.
Main Results:
- sCRCs showed higher mutation rates in APC and PIK3CA compared to CACs.
- The KRAS G12D mutation was specific to the CAC cohort.
- Conventional CACs exhibited significantly more ATM mutations than non-conventional types.
Conclusions:
- Genetic profiles reveal distinct differences between sCRC and CAC.
- Specific gene alterations can serve as biomarkers to support pathological diagnosis.
Keywords:
Colitis-associated carcinomaConventional carcinomaMutationNon-conventional carcinomaSporadic carcinomaUlcerative colitis
